Besides that, data from HD animal model showed AKT to be up-regulated with the intranasal administration of recombinant human IGF-1, increasing phosphorylation of mutant Htt and leading to an improvement in motor activity, as well as in both peripheral and central metabolic abnormalities (Lopes et al., 2014). Here, IGF1 is linked to Huntington disease.